CRL vs XRX · rev $2.00B vs rev $1.92B
Charles River Laboratories (CRL) versus Xerox Corp (XRX) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Xerox Corp (XRX) is a business equipment & supplies company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported XRX revenue for 2026-06-30 was $1.92B. Net income was $13.0M. Revenue was up 4.1% from 2026-03-31 to 2026-06-30. XRX currently screens at market cap $410.6M.
CRL currently screens at market cap $7.78B. XRX currently screens at market cap $410.6M.
Not investment advice. Open the CRL and XRX stock pages for the full models.
Not investment advice.